Pragmatic Trials across the Cancer Control Continuum (UG3/UH3 Clinical Trial Required)
ArchivedNational Institutes of Health
Description
Through this notice of funding opportunity (NOFO), the National Cancer Institute (NCI) intends to accelerate the development of evidence-based cancer-related interventions to improve health access for all and reflect a variety of people, places, contexts, and settings in the United States. Specifically, this FOA will support research that tests the impact of cancer-related interventions on cancer-related outcomes across the cancer control continuum using a pragmatic trial study design. This FOA will use the UG3/UH3 phased cooperative agreement mechanism. The UG3 phase will support refining the cancer-related intervention and finalizing study-related activities in preparation for conducting the pragmatic trial during the UH3 phase.
Who can apply
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities / Indian housing authorities
- Native American tribal organizations (other than Federally recognized)
- Nonprofits with 501(c)(3) status (other than higher education)
- Nonprofits without 501(c)(3) status (other than higher education)
- Private institutions of higher education
- For-profit organizations other than small businesses
- Small businesses
- Others
Contact
NIH Grants Information <br/>grantsinfo@nih.gov
grantsinfo@nih.gov
- PostedNov 18, 2024
- ClosesNov 17, 2025
- CFDA93.399
Pro insight
Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.
Unlock with Pro